MLKL and liver disorder: Further research has shown that AAV8-mediated knockdown of MLKL, which is the ultimate effector of the necroptosis signal pathway, significantly attenuates CCl4-induced hepatic fibrosis, indicating that MLKL-modulated necroptosis plays an essential role in liver disease and fibrosis.